PMLiVE | Pharmaceutical industry news, articles, jobs, reports, …
WEBOptimizing Patient Recruitment & Retention in Influenza Studies. Aug 16, 2024 Webinars. With the flu season rapidly approaching, there is a surge in influenza and vaccine-related studies. These studies often face the significant challenge of a very short recruitment window, which necessitates thorough preparation and strategic planning during ...
PME - PMLiVE
WEBPharmaceutical Market Europe – October 2023. Launch excellence – adapting to data disruption; preparing for the clinical trials of the future; the impact of cell therapies on cancer treatments.
Research - PMLiVE
WEBFeb 23, 2024 · Merck shares positive ten-year results for Keytruda in advanced melanoma. Sep 16, 2024 | News, Research. More than 100,640 cases of the skin cancer are expected to be diagnosed in the US this year. Read More.
FDA approves Pfizer/BioNTech and Moderna’s updated COVID-19 …
WEBSep 12, 2023 · The US Food and Drug Administration (FDA) has approved updated COVID-19 vaccines from Pfizer/BioNTech and Moderna to more closely target currently circulating variants.
Regulatory - PMLiVE
WEBNovartis’ Fabhalta recommended by NICE to treat rare blood disorder PNH. Sep 4, 2024 News Regulatory. Paroxysmal nocturnal haemoglobinuria affects approximately ten to 20 people per million worldwide. Read More.
Sales - PMLiVE
WEBEli Lilly and Genetic Leap partner to develop RNA-targeted therapies in deal worth $409m. Sep 10, 2024 | News, Sales. The companies will use Genetic Leap’s AI platform to generate oligonucleotide drugs against targets selected by Lilly. Read More.
Healthcare - PMLiVE
WEBEli Lilly commits further $6.5m to UNICEF for young people at risk of noncommunicable diseases. Jun 4, 2024 | News, Healthcare. The new funding builds on the company’s initial commitment of $14.4m in 2022. Read More.
PME - Home
WEBHow AI and digital innovations can help agencies and pharma support HCPs in the fight against COVID-19 - PME Supplement August 2020. As the realities of COVID-19 hit and lockdown restrictions came into force around the world, agencies and pharma suddenly found themselves embracing AI and digital innovations at an accelerated rate.
PME - Home - PMLiVE
WEBHow AI and digital innovations can help agencies and pharma support HCPs in the fight against COVID-19 - PME Supplement August 2020. As the realities of COVID-19 hit and lockdown restrictions came into force around the world, agencies and pharma suddenly found themselves embracing AI and digital innovations at an accelerated rate.
Allergan pushes on with Botox for depression - PMLiVE
WEBApr 7, 2017 · Allergan pushes on with Botox for depression. Allergan has reported mixed top-line data from a mid-stage trial of its wrinkle treatment Botox in patients with major depressive disorder (MDD), but still thinks it is worth testing the drug in phase III. The specialty pharma group took the decision to test Botox in depression after external ...
Skip to content